AXP DELIVERS SIGNIFICANT INCREASE IN RESERVES
LEXINGTON, Ky., Sept. 30, 2022 /PRNewswire/ -- AXP Energy Limited (ASX: AXP, OTC US: AUNXF), ('AXP', 'Company') is pleased to provide an updated estimate of its Reserves and Contingent Resources as at1 July 2022 (the 'Evaluation Date'). The Reserves and Contingent Resources ('R&R') below are net ...
Reserves And Resources Update
NEW YORK, Nov. 26, 2021 /PRNewswire/ -- AXP Energy Limited (ASX: AXP, OTC US: AUNXF), ('AXP', 'Company') announces its assessment of Reserves and Contingent Resources as at 1 October 2021. The Reserves and Resources below arenet to AXP unless stated otherwise. They include, for the first time, ...
Acquisition of 100% of Kentucky Exploration Leases
SYDNEY, Nov. 19, 2021 /PRNewswire/ -- AXP Energy Limited (ASX: AXP, OTC US: AUNXF), ("AXP", "Company") is pleased to confirm that it has agreed terms with Australian private company Newtak Pty Ltd ("Newtak") to acquire Newtak's 50% membership interest in Kentucky Exploration, LLC, resulting in A...
North American Trading in AXP Shares
HIGHLIGHTS * Lodgement made to OTC Markets Group to upgrade to the OTCQB® Venture Market * Up-listing to the OTCQB® Venture Market is being sponsored by MCAP LLC * Also pursuing electronic clearing and settlement through the Depository Trust & Clearing Corporation ("DTCC") inthe United State...
AXP Energy Limited (OTC US: AUNXF, ASX: AXP) announces newly formed drilling division to advance 8-well program
HIGHLIGHTS * AXP has formed an in-house drilling function staffed with existing team members to undertake an internally-funded 4 + 4 well vertical well drill program in theIllinois and Appalachian Basins; * Company has internal geological, drilling and field service capabilities which will o...
AirXpanders® Announces Reduction in Force and Plan to Cease Operations
SAN JOSE, California, July 17, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the Company has reduced its workforce and plans to cease operations. ...
AirXpanders® Receives FDA 510(k) Clearance for a Smooth Shell Version of the AeroForm® Tissue Expander System
SAN JOSE, California, July 15, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the company has received U.S. Food and Drug Administration (FDA) 510(k...
AirXpanders® Announces Special 510(k) Submission to the US FDA for a Smooth Shell Version of the AeroForm® Tissue Expander System
SAN JOSE, California, May 13, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the company has submitted a Special 510(k) pre-market notification to t...
AirXpanders Engages Cowen to Explore Financial and Strategic Alternatives
SAN JOSE, California, May 9, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the Company has retained Cowen as an independent financial advisor to as...
AirXpanders and Radformation Announce Co-Marketing Agreement
Partnership Designed to Bring Improved Workflow to Radiation Oncology Departments SAN JOSE, California, April 8, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, andRadfo...
AirXpanders Announces New Data Demonstrating Reduced Infection Rates and Decreased Utilization of Healthcare Resources Associated with AeroForm
SAN JOSE, California, April 4, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP),a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced the publication of a large retrospective clinical study by Chopra, et al. wh...
AirXpanders Provides Update on Strategic Purchasing Agreements with Several Academic Medical Centers
SAN JOSE, California, March 13, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP),a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today provided an update on strategic agreements with prestigious academic medical centers ...
AirXpanders Announces 4,000th AeroForm Implant
SAN JOSE, California, Nov. 26, 2018 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP),a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced the 4,000 th commercial worldwide placement of AeroForm Tissue Expander was r...
